Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Ascending Single Dose Study of the Pharmacokinetics, Safety and Tolerability of Hemay005 in Healthy Male Subjects

NCT03007810 is registered in ClinicalTrials.gov with Tianjin Hemay Bio-Tech Co., Ltd as lead sponsor.

NCT NCT03007810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03007810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Ascending Single Dose Study of the Pharmacokinetics, Safety and Tolerability of Hemay005 in Healthy Male Subjects
Lead sponsor
Tianjin Hemay Bio-Tech Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2016
Completion date
June 30, 2018
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis